The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Tumors exhibit phenotypic heterogeneity, containing cancer stem cells.
• Salinomycin, a K+-selective ionophore, shows selectivity against cancer stem cells.
• The Wnt signaling pathway is implicated in salinomycin's selective effect, but the mechanism is unclear.

Purpose of the Study:

• To investigate the molecular mechanism of salinomycin's selective action against cancer stem cells.
• To elucidate the role of ion fluxes in salinomycin's effects.

Main Methods:

• Development of a fluorescent salinomycin conjugate.
• Subcellular imaging to track conjugate localization and calcium (Ca2+) release.
• Global mRNA analysis and Western blot to study the unfolded protein response and Wnt pathway components.

Main Results:

• Salinomycin rapidly enters cells and accumulates in the endoplasmic reticulum (ER).
• Salinomycin induces Ca2+ release from the ER into the cytosol, triggering the unfolded protein response.
• ER Ca2+ depletion up-regulates CHOP, inhibiting Wnt signaling by down-regulating β-catenin. Increased cytosolic Ca2+ also activates protein kinase C, further inhibiting Wnt signaling.

Conclusions:

• Salinomycin acts on ER membranes to enhance Ca2+ release, likely via K+ ion flux.
• Ion fluxes in the ER are critical for inducing phenotypic effects in cancer cells.
• This mechanistic understanding can guide the development of novel cancer therapies.